{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:35:05Z","timestamp":1784039705511,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11906-021-01150-9","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T03:33:33Z","timestamp":1622086413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients"],"prefix":"10.1007","volume":"23","author":[{"given":"Meredith L.","family":"Seamon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuyo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kadakia R, Bianco M, Dabrowski E, Zimmerman D. Pheochromocytoma and paraganglioma in the pediatric population. In: Landsberg L, editor. Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System. 1st ed: Contemporary Endocrinology: Humana Press; 2018. p. 89\u201397. Recent book chapter on pediatric PPGL, which highlights the importance of genetic testing and reviews the hereditary syndromes associated with PPGL with a case-based approach. General diagnostic and management approaches are also reviewed.","DOI":"10.1007\/978-3-319-77048-2_5"},{"issue":"3","key":"1150_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"AK Lam","year":"2017","unstructured":"Lam AK. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol. 2017;28(3):213\u201327. https:\/\/doi.org\/10.1007\/s12022-017-9484-5.","journal-title":"Endocr Pathol."},{"issue":"4","key":"1150_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00467-018-4181-2","volume":"35","author":"A Jain","year":"2020","unstructured":"\u2022\u2022 Jain A, Baracco R, Kapur G. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management. Pediatr Nephrol. 2020;35(4):581\u201394. https:\/\/doi.org\/10.1007\/s00467-018-4181-2Current review of management of pediatric patients with PPGL including appropriate biochemical testing and imaging studies as well as presentation of a systematic approach to pre-operative blood pressure control. Includes discussion of the importance of genetic testing in pediatric patients as well as the common germline mutations associated with PPGL.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"1150_CR4","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.3747\/co.21.1579","volume":"21","author":"M Lefebvre","year":"2014","unstructured":"Lefebvre M, Foulkes WD. Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol. 2014;21(1):e8\u201317. https:\/\/doi.org\/10.3747\/co.21.1579.","journal-title":"Curr Oncol."},{"key":"1150_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1353.003","volume":"1073","author":"M Barontini","year":"2006","unstructured":"Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073:30\u20137. https:\/\/doi.org\/10.1196\/annals.1353.003.","journal-title":"Ann N Y Acad Sci."},{"key":"1150_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","volume":"51","author":"A Berends","year":"2018","unstructured":"Berends A, Buitenwerf E, de Krijger RR, Veeger N, van der Horst-Schrivers A, Links TP, et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. European Journal of Internal Medicine. 2018;51:68\u201373. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.015.","journal-title":"European Journal of Internal Medicine."},{"issue":"4","key":"1150_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2016-3829","volume":"102","author":"C Pamporaki","year":"2017","unstructured":"\u2022\u2022 Pamporaki C, Hamplova B, Peitzsch M, Prejbisz A, Beuschlein F, Timmers H, et al. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2017;102(4):1122\u201332. https:\/\/doi.org\/10.1210\/jc.2016-3829Retrospective review of more than 700 patients with PPGL from seven tertiary centers, including 95 patients who presented in childhood, which highlights the differences in pediatric patients compared to adults. The authors designate two categories, cluster 1 and cluster 2, for hereditary PPGLs based on mutations related to hypoxia and kinase receptor signaling pathways, respectively.","journal-title":"J Clin Endocrinol Metab"},{"key":"1150_CR8","doi-asserted-by":"publisher","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3). https:\/\/doi.org\/10.1542\/peds.2017-1904.","DOI":"10.1542\/peds.2017-1904"},{"issue":"6","key":"1150_CR9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342. https:\/\/doi.org\/10.1210\/jc.2014-1498.","journal-title":"J Clin Endocrinol Metab."},{"key":"1150_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fped.2017.00155","volume":"5","author":"R Bholah","year":"2017","unstructured":"\u2022 Bholah R, Bunchman TE. Review of pediatric pheochromocytoma and paraganglioma. Front Pediatr. 2017;5:155. https:\/\/doi.org\/10.3389\/fped.2017.00155Recent review of the approach to pediatric patients with PPGL, including a table highlighting the other causes of secondary hypertension one must consider when evaluating children with hypertension. The authors also discuss genetic syndromes associated with PPGL and offer a particularly useful diagnostic algorithm regarding biochemical testing and imaging studies.","journal-title":"Front Pediatr"},{"issue":"3","key":"1150_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1542\/peds.2005-2299","volume":"118","author":"TH Pham","year":"2006","unstructured":"Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, Farley D, et al. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics. 2006;118(3):1109\u201317. https:\/\/doi.org\/10.1542\/peds.2005-2299.","journal-title":"Pediatrics."},{"issue":"1","key":"1150_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/0971-5851.203503","volume":"38","author":"PK Tripathy","year":"2017","unstructured":"Tripathy PK, Pattnaik K, Nayak M, Mohanty HK. Pheochromocytoma in a child without hypertension: a contribution to the \u201crule of 10s\u201d. Indian J Med Paediatr Oncol. 2017;38(1):59\u201361. https:\/\/doi.org\/10.4103\/0971-5851.203503.","journal-title":"Indian J Med Paediatr Oncol."},{"issue":"4","key":"1150_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s13312-014-0397-9","volume":"51","author":"A Mishra","year":"2014","unstructured":"Mishra A, Mehrotra PK, Agarwal G, Agarwal A, Mishra SK. Pediatric and adolescent pheochromocytoma: clinical presentation and outcome of surgery. Indian Pediatr. 2014;51(4):299\u2013302. https:\/\/doi.org\/10.1007\/s13312-014-0397-9.","journal-title":"Indian Pediatr."},{"key":"1150_CR14","doi-asserted-by":"crossref","unstructured":"\u2022 Batsis M, Dagalakis U, Stratakis CA, Prodanov T, Papadakis GZ, Adams K et al. Attention deficit hyperactivity disorder in pediatric patients with pheochromocytoma and paraganglioma. Horm Metab Res. 2016;48(8):509-513. doi:10.1055\/s-0042-106725. Recent case series highlighting the increased prevalence of ADHD symptomatology in pediatric patients with PPGL compared to the general pediatric population. This study is of importance to the clinician considering initiation of stimulant medications in children with ADHD who also have hypertension, as screening to evaluate PPGL is warranted.","DOI":"10.1055\/s-0042-106725"},{"issue":"7","key":"1150_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11906-014-0442-z","volume":"16","author":"JM Pappachan","year":"2014","unstructured":"Pappachan JM, Raskauskiene D, Sriraman R, Edavalath M, Hanna FW. Diagnosis and management of pheochromocytoma: a practical guide to clinicians. Curr Hypertens Rep. 2014;16(7):442. https:\/\/doi.org\/10.1007\/s11906-014-0442-z.","journal-title":"Curr Hypertens Rep."},{"issue":"5","key":"1150_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/MOU.0000000000000650","volume":"29","author":"L Peard","year":"2019","unstructured":"Peard L, Cost NG, Saltzman AF. Pediatric pheochromocytoma: current status of diagnostic imaging and treatment procedures. Curr Opin Urol. 2019;29(5):493\u20139. https:\/\/doi.org\/10.1097\/MOU.0000000000000650.","journal-title":"Curr Opin Urol."},{"key":"1150_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","volume":"32","author":"JWM Lenders","year":"2017","unstructured":"Lenders JWM, Eisenhofer G. Update on modern management of pheochromocytoma and paraganglioma. Endrocrinol Metab. 2017;32:152\u201361. https:\/\/doi.org\/10.3803\/EnM.2017.32.2.152.","journal-title":"Endrocrinol Metab"},{"key":"1150_CR18","doi-asserted-by":"publisher","unstructured":"Sait S, Pandit-Taskar N, Modak S. Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma. Pediatr Blood Cancer. 2017;64(11). https:\/\/doi.org\/10.1002\/pbc.26549.","DOI":"10.1002\/pbc.26549"},{"issue":"2","key":"1150_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/bja\/aew392","volume":"118","author":"H Groeben","year":"2017","unstructured":"Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK. Perioperative alpha-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth. 2017;118(2):182\u20139. https:\/\/doi.org\/10.1093\/bja\/aew392.","journal-title":"Br J Anaesth."},{"issue":"2","key":"1150_CR20","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1002\/bjs.11378","volume":"107","author":"H Groeben","year":"2020","unstructured":"\u2022\u2022 Groeben H, Walz MK, Nottebaum BJ, Alesina PF, Greenwald A, Schumann R, et al. International multicentre review of perioperative management and outcome for catecholamine-producing tumours. Br J Surg. 2020;107(2):e170\u2013e8. https:\/\/doi.org\/10.1002\/bjs.11378A multicenter, international review of nearly 1900 patients with PPGL from 21 centers, which highlighted the outcome of a cohort of these patients who underwent surgery without \u03b1-receptor blockade. The authors discuss that further studies are warranted to define the ideal approach with possible review of international preoperative guidelines.","journal-title":"Br J Surg"},{"issue":"4","key":"1150_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1067\/j.cpsurg.2013.12.001","volume":"51","author":"R Hodin","year":"2014","unstructured":"Hodin R, Lubitz C, Phitayakorn R, Stephen A. Diagnosis and management of pheochromocytoma. Curr Probl Surg. 2014;51(4):151\u201387. https:\/\/doi.org\/10.1067\/j.cpsurg.2013.12.001.","journal-title":"Curr Probl Surg."},{"issue":"6","key":"1150_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, O\u2019Dorisio MS, Vinik AI, Lloyd RV, Pacak K, et al. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39(6):775\u201383. https:\/\/doi.org\/10.1097\/MPA.0b013e3181ebb4f0.","journal-title":"Pancreas."},{"issue":"9","key":"1150_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/jch.12571","volume":"17","author":"M Romero","year":"2015","unstructured":"\u2022 Romero M, Kapur G, Baracco R, Valentini RP, Mattoo TK, Jain A. Treatment of hypertension in children with catecholamine-secreting tumors: a systematic approach. J Clin Hypertens (Greenwich). 2015;17(9):720\u20135. https:\/\/doi.org\/10.1111\/jch.12571The authors present their single center experience on management of pediatric patients with PPGL (and neuroblastoma), and propose an algorithm for the preoperative management that utilizes phenoxybenzamine in incremental doses followed by \u03b2-blockade with atenolol, labetalol, or propranolol.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1150_CR24","unstructured":"Phenoxybenzamine. In: Lexi-Drugs online [database on the Internet]. Hudson (OH): Lexicomp Inc.: 2020 [updated 25 Feb 2021; cited 14 Mar 2021]. Available from: http:\/\/online.lexi.com. Subscription required to view. Accessed: 14 Mar 2021"},{"issue":"6","key":"1150_CR25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.surg.2012.08.023","volume":"152","author":"HK Siddiqi","year":"2012","unstructured":"Siddiqi HK, Yang HY, Laird AM, Fox AC, Doherty GM, Miller BS, et al. Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery. 2012;152(6):1027\u201336. https:\/\/doi.org\/10.1016\/j.surg.2012.08.023.","journal-title":"Surgery."},{"issue":"4","key":"1150_CR26","first-page":"190","volume":"72","author":"PA van der Zee","year":"2014","unstructured":"van der Zee PA, de Boer A. Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin. Neth J Med. 2014;72(4):190\u2013201.","journal-title":"Neth J Med."},{"issue":"3","key":"1150_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1515\/enr-2017-0018","volume":"51","author":"FA Farrugia","year":"2017","unstructured":"Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, et al. Pheochromocytoma, diagnosis and treatment: review of the literature. Endocr Regul. 2017;51(3):168\u201381. https:\/\/doi.org\/10.1515\/enr-2017-0018.","journal-title":"Endocr Regul."},{"issue":"11","key":"1150_CR28","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.5603\/KP.a2017.0147","volume":"75","author":"K Malec","year":"2017","unstructured":"Malec K, Miskiewicz P, Witkowska A, Krajewska E, Toutounchi S, Galazka Z, et al. Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma. Kardiol Pol. 2017;75(11):1192\u20138. https:\/\/doi.org\/10.5603\/KP.a2017.0147.","journal-title":"Kardiol Pol."},{"issue":"11","key":"1150_CR29","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1177\/000313481307901125","volume":"79","author":"G Conzo","year":"2013","unstructured":"Conzo G, Musella M, Corcione F, Depalma M, Stanzione F, Della-Pietra C, et al. Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases. Am Surg. 2013;79(11):1196\u2013202.","journal-title":"Am Surg."},{"key":"1150_CR30","unstructured":"Doxazosin. In: Lexi-Drugs online [database on the Internet]. Hudson (OH): Lexicomp Inc.: 2020 [updated 24 Oct 2020; cited 2 Dec 2020]. Available from: http:\/\/online.lexi.com. Subscription required to view. Accessed: 2 Dec 2020"},{"issue":"6","key":"1150_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00268-004-7134-9","volume":"28","author":"DG Beltsevich","year":"2004","unstructured":"Beltsevich DG, Kuznetsov NS, Kazaryan AM, Lysenko MA. Pheochromocytoma surgery: epidemiologic peculiarities in children. World J Surg. 2004;28(6):592\u20136. https:\/\/doi.org\/10.1007\/s00268-004-7134-9.","journal-title":"World J Surg."},{"issue":"5","key":"1150_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2044.2005.04156.x","volume":"60","author":"G Lebuffe","year":"2005","unstructured":"Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, et al. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia. 2005;60(5):439\u201344. https:\/\/doi.org\/10.1111\/j.1365-2044.2005.04156.x.","journal-title":"Anaesthesia."},{"issue":"3","key":"1150_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.maturitas.2013.12.009","volume":"77","author":"A Tsirlin","year":"2014","unstructured":"Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA. Pheochromocytoma: a review. Maturitas. 2014;77(3):229\u201338. https:\/\/doi.org\/10.1016\/j.maturitas.2013.12.009.","journal-title":"Maturitas."},{"issue":"3","key":"1150_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/1119-3077.100616","volume":"15","author":"R Domi","year":"2012","unstructured":"Domi R, Laho H. Management of pheochromocytoma: old ideas and new drugs. Niger J Clin Pract. 2012;15(3):253\u20137. https:\/\/doi.org\/10.4103\/1119-3077.100616.","journal-title":"Niger J Clin Pract."},{"issue":"6","key":"1150_CR35","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.surg.2014.08.022","volume":"156","author":"L Brunaud","year":"2014","unstructured":"Brunaud L, Boutami M, Nguyen-Thi PL, Finnerty B, Germain A, Weryha G, et al. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery. 2014;156(6):1410\u20137; discussion7-8. https:\/\/doi.org\/10.1016\/j.surg.2014.08.022.","journal-title":"Surgery"},{"key":"1150_CR36","unstructured":"Metyrosine. In: Lexi-Drugs online [database on the Internet]. Hudson (OH): Lexicomp Inc.: 2020 [updated 24 Oct 2020; cited 5 Dec 2020]. Available from: http:\/\/online.lexi.com. Subscription required to view. Accessed: 5 Dec 2020"},{"issue":"1","key":"1150_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11845-015-1383-5","volume":"185","author":"N Azadeh","year":"2016","unstructured":"Azadeh N, Ramakrishna H, Bhatia NL, Charles JC, Mookadam F. Therapeutic goals in patients with pheochromocytoma: a guide to perioperative management. Ir J Med Sci. 2016;185(1):43\u20139. https:\/\/doi.org\/10.1007\/s11845-015-1383-5.","journal-title":"Ir J Med Sci."},{"issue":"4","key":"1150_CR38","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1053\/j.jvca.2017.02.023","volume":"31","author":"J Naranjo","year":"2017","unstructured":"Naranjo J, Dodd S, Martin YN. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2017;31(4):1427\u201339. https:\/\/doi.org\/10.1053\/j.jvca.2017.02.023.","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"1150_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s_0032_1306275","volume":"44","author":"M Mannelli","year":"2012","unstructured":"Mannelli M, Dralle H, Lenders JWM. Perioperative management of pheochromocytoma\/paraganglioma: is there a state of the art? Horm Metab Res. 2012;44:373\u20138. https:\/\/doi.org\/10.1055\/s_0032_1306275.","journal-title":"Horm Metab Res."},{"issue":"19","key":"1150_CR40","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJM198405103101917","volume":"310","author":"O Serri","year":"1984","unstructured":"Serri O, Comtois R, Bettez P, Dubuc G, Buu NT, Kuchel O. Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy. N Engl J Med. 1984;310(19):1264\u20135. https:\/\/doi.org\/10.1056\/NEJM198405103101917.","journal-title":"N Engl J Med"},{"issue":"6","key":"1150_CR41","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.amjsurg.2007.08.028","volume":"194","author":"AD Ludwig","year":"2007","unstructured":"Ludwig AD, Feig DI, Brandt ML, Hicks MJ, Fitch ME, Cass DL. Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg. 2007;194(6):792\u20136; discussion 6-7. https:\/\/doi.org\/10.1016\/j.amjsurg.2007.08.028.","journal-title":"Am J Surg."},{"issue":"13","key":"1150_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJM198703263161307","volume":"316","author":"J Imperato-McGinley","year":"1987","unstructured":"Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED Jr. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med. 1987;316(13):793\u20137. https:\/\/doi.org\/10.1056\/NEJM198703263161307.","journal-title":"N Engl J Med."},{"issue":"2","key":"1150_CR43","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.15460","volume":"4","author":"GC Rajappa","year":"2014","unstructured":"Rajappa GC, Anandaswamy TC. Laparoscopic cortical sparing adrenalectomy for pediatric bilateral pheochromocytoma: anesthetic management. Anesth Pain Med. 2014;4(2):e15460. https:\/\/doi.org\/10.5812\/aapm.15460.","journal-title":"Anesth Pain Med."},{"issue":"1","key":"1150_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/ERC-13-0415","volume":"21","author":"B Bausch","year":"2014","unstructured":"Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, et al. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer. 2014;21(1):17\u201325. https:\/\/doi.org\/10.1530\/ERC-13-0415.","journal-title":"Endocr Relat Cancer."}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01150-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-021-01150-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01150-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T08:34:16Z","timestamp":1622709256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-021-01150-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1007\/s11906-021-01150-9","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"27 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"32"}}